Dr. Thomas Dobmeyer studied medicine at the University of Mainz and the University of Montpellier in France. During and after his doctoral work at the department of dermatology at the University of Mainz, he worked as an assistant physician and directed a research group at the Frankfurt University Hospital.
After research stays in France and Germany, in the department of viral oncology at the Pasteur Institute in Paris, and in the department of immunology at the Paul Ehrlich Institute in Langen, he began working as a medical advisor at YES Pharma Services GmbH in 1997. During the same period, he completed a post-graduate programme of study in “clinical evaluation” at the medical faculty of the University of Marburg. From 2000 to 2002 he worked in France for Biogen International as Medical Affairs Manager before returning to YES once again as Director of Medical Affairs.
In 2002 he assumed the position of Managing Partner at YES Pharmaceutical Development Services (today PharmaLex) and since 2007 he has also been Managing Director of YES Medical Device Services GmbH. Since 2015 Dr Dobmeyer is CEO of the PharmaLex/YES Group.
Dr Dobmeyer is a member of the German Society for Pharmaceutical Medicine (DGPPharMed) and the German Society for Regulatory Affairs (DGRA).